Skip to main content
Scientific reviewStaged researchTransparent fundingNo guaranteed outcomes

Understanding the genetic diagnosis behind Angelman syndrome

A test name matters. 'Genetic testing was normal' does not tell you whether methylation, copy-number changes, UBE3A sequence variants, UPD, or imprinting mechanisms were evaluated.

Diagram of chromosome 15q11-q13 showing the SNHG14 imprinting centre and UBE3A gene expression in maternal versus paternal inheritance
The appropriate sequence depends on the clinical situation and laboratory methods. This page is an educational overview, not a universal medical order.

Why one test may not answer every question

Different methods answer different questions. A normal result from one test does not rule out every Angelman mechanism. The report should state exactly which methods were used and which mechanisms were assessed.

Diagnostic pathway overview

Clinical suspicionMethylation-based testingMechanism clarificationUBE3A analysis where appropriateBroader differential testing when needed

Main molecular mechanisms

15q11.2–q13 deletion

A missing segment on the maternal copy of chromosome 15 that includes UBE3A.

UBE3A pathogenic variant

A sequence change within the UBE3A gene that reduces or removes function.

Paternal uniparental disomy (UPD)

Both copies of chromosome 15 are inherited from the father.

Imprinting defect

The maternal UBE3A gene is present but not properly activated.

What common methods detect

MethodMain questionMechanisms commonly detectedImportant limitationsDoes it define the exact mechanism?
DNA methylation analysisIs the maternal UBE3A region methylated/active?Detects most deletions, UPD, and imprinting defectsMay miss some UBE3A point variants; does not identify the exact mechanism in all casesNo — usually needs follow-up testing
MS-MLPAAre copy-number and methylation patterns abnormal?Deletions, some imprinting defectsMay not detect all sequence variants or UPD without additional analysisCan define deletion and some imprinting findings
Chromosomal microarrayAre there copy-number changes in the 15q region?Large deletions and duplicationsDoes not detect methylation, UPD, or small sequence variantsDefines deletion size but not mechanism alone
FISHIs a specific 15q region deleted?Large deletionsLow resolution; does not detect methylation, UPD, or sequence variantsNo — limited resolution
UBE3A sequencingAre there sequence variants in UBE3A?UBE3A pathogenic variantsMay miss large intragenic deletions/duplications or methylation defectsYes, when a pathogenic variant is identified
UBE3A deletion/duplication analysisAre there intragenic copy-number changes?UBE3A exon-level deletions or duplicationsDoes not detect point variants or methylation defectsYes, when confirmed
UPD analysisAre both chromosome 15 copies from one parent?Paternal UPDDoes not detect deletions or sequence variantsYes, when confirmed
Exome/genome sequencingAre there variants in UBE3A or other genes?UBE3A variants and Angelman-like differential diagnosesMay not detect methylation or imprinting defects; interpretation can be uncertainSometimes; depends on the finding

Not sure what your previous tests covered?

A genetic report review can map the methods used, the mechanisms assessed, and the questions that still need answers.

You can begin with a document review. You do not need to commit to a research project.